NICE technology appraisal guidance
Issued: April 2009
TA170

Rivaroxaban for the prevention of venous thromboembolism after total hip or total knee replacement in adults

This is an extract from the guidance. The complete guidance is available at guidance.nice.org.uk/ta170

7 Related NICE guidance